Carrión-Camacho Mª Reyes, Marín-León Ignacio, Molina-Doñoro José Manuel, González-López José Rafael
Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, Universidad de Sevilla, 41009 Seville, Spain.
Clinical Management Unit-Anesthesiology and Resuscitation, Cardiac Surgery, Virgen del Rocío University Hospital, 41013 Seville, Spain.
J Clin Med. 2019 Jan 1;8(1):35. doi: 10.3390/jcm8010035.
Although pacemaker implantation is considered to be low risk, it is not exempt from complications and technical failures during the procedure, both in the short and long term, and the complications that such patients may present remain unknown. The aim has been to analyze the complication rates associated with permanent pacing and to identify if these differ between patients with or without previous antithrombotic therapy. We used a prospective, single center, observational study of 310 adult patients with indications of permanent pacing. They were hospitalized from 1 January to 31 December 2014 and followed up for 6 months after the pacemaker implant. The participants were distributed into two groups according to the antithrombotic therapy prior to the implant. The most frequent major complications were pneumothorax (3.87%) and lead dislodgement (8.39%), while superficial phlebitis (12.90%) and uncomplicated hematomas (22.58%) were presented as the most recurrent minor complications. Hematomas were the most frequent minor complication in the antithrombotic therapy cohort, and shoulder pain was reported as the most recurrent minor complication in the non-exposed group. Finding out about complications in pacemaker implants enables a complete view of the process, and hence the prioritization of actions aimed at improving safety and reducing associated risks.
尽管起搏器植入被认为风险较低,但在手术过程中,无论短期还是长期,都无法避免并发症和技术故障,而且这类患者可能出现的并发症仍然未知。目的是分析与永久性起搏相关的并发症发生率,并确定在接受或未接受过抗血栓治疗的患者之间是否存在差异。我们对310例有永久性起搏指征的成年患者进行了一项前瞻性、单中心观察性研究。他们于2014年1月1日至12月31日住院,并在起搏器植入后随访6个月。根据植入前的抗血栓治疗情况,将参与者分为两组。最常见的主要并发症是气胸(3.87%)和导线脱位(8.39%),而浅表静脉炎(12.90%)和无并发症的血肿(22.58%)是最常见的次要并发症。血肿是抗血栓治疗队列中最常见的次要并发症,而肩部疼痛是未接受抗血栓治疗组中最常见的次要并发症。了解起搏器植入的并发症能够全面了解整个过程,从而确定旨在提高安全性和降低相关风险的行动的优先级。